Market-View-Feature-Image

View on market: Stay Cautious, be with quality business:

Asian stocks rose Tuesday after a climb in U.S. equities, a slump in crude oil and the prospect of more cease-fire talks between Russia and Ukraine helped to support investor sentiment. Oil extended a slide, taking West Texas Intermediate crude to about $105 a barrel, on concerns that China’s mobility curbs against Covid will sap demand. Singapore-traded SGX Nifty, an early barometer of India’s benchmark Nifty 50 index, rose 1.2% to 17,423.8 points as of 6:10 a.m. The dollar trimmed a gain, while the yen was around a six-year low against the greenback on the divergence between the hawkish Fed and dovish Japanese central bank.

Economic Calendar:

  • INR: Export Data on 1st April 2022.
  • INR: Forex Reserve on 1st April 2022.
  • USD: GDP Quarter4 30th March, 2022.
  • USD: Non Payroll Employement on 28th March, 2022.

Brokerage Radar:

JEFFERIES ON NEWGEN SOFTWARE: Buy, TP cut to Rs 650 In recent meeting, CEO & CFO highlighted that Middle East & APAC regions are doing well but US is lagging due to high employee attrition at clients, which is delaying decision-making Rev from SI-led engagements are also being delayed.

CREDIT SUISSE ON BHARTI AIRTEL: O-P, TP Rs 900 Well positioned to be one of leading integrated telcos in India Airtel expects TAM for its emerging enterprise product offerings to post a 25% CAGR to Rs700bn by 2025 & has revamped its strategy to go wider & deeper among its ent customers.

CREDIT SUISSE ON SBI CARDS: O-P, TP Rs 1100 Notes from AIC: Co remains confident in continued market share gains on cards outstanding & spends. Asset quality trends remain healthy & will likely continue to improve.

CREDIT SUISSE ON VOLTAS: Neutral, TP Rs 1225 Scorching summer & other challenges; prefer Havells over Voltas Revise earnings by -7% for FY22,23,24E to a/c for margin impact of higher commodities Believe risk reward is better in Havells which has a more diversified biz & at cheaper valuations.

CLSA ON MAX FINANCIAL: Buy, TP cut to Rs 1030 from Rs 1100 Val @ 1.7x/1.5x FY23/24 P/EV, is getting undemanding Operating entities may be insulated from a promoter group feud but this could be short-term headwind with the promoter pledge at 64%.

CLSA ON CHOLA INVESTMENT: Downgrade to O-P from buy, TP raised to Rs 825 Vehicle finance recovery story continues to play-out Barring 2W & tractors, all auto products are seeing a sequential pick-up Lift FY23-24 PAT est 1-4% See limited upside post recent O-P

International Markets:

U.S & Europe:

Particulars 25th Mar Chg Chg(%)
Nasdaq 14,354.90 185.6 1.31
Dow 34955.89 94.65 0.27
FTSE 7,473.14 -10.21 -0.14
CAC 6,589.11 35.43 0.54
DAX 14,417.37 111.61 0.78
Dow Fut.* 34977.3 22.4 0.06

Asian markets:

Particulars 28th  Mar Chg. Chg(%)
SGX Nifty 17,375.50 96 0.56
Nikkei 28,110.73 166.84 0.6
Straits Times 3,437.40 5.41 0.16
Hang Seng 21,778.54 93.57 0.43
Shanghai 3,207.38 -7.12 -0.22

 

ADR Watch:

Particulars 25th Mar Chg. Chg.(%)
Dr Reddy 55.23 -1.02 -1.81
HDFC Bank 60.27 -0.01 -0.02
ICICI Bank 18.56 0.37 2.03
Infosys 24.72 -0.01 -0.04
Tata Motor 28.54 0.14 0.49
Wipro 7.92 0.02 0.25

Commodities & Currency:

Particulars Current Price Chg(%)
USD/INR 76.16 -0.06
Brent 108.84 -0.64
Gold 1962.55  -0.67
Silver 25.105  -0.35

FIIs & DII:

Particulars 25th Mar 24th Mar
FIIs -801.41 -1740.71
DIIs 1161.70 2091.07

News Update:

Tata Power: The company and Rustomjee Group have collaborated to set up electric vehicle charging infrastructure at the commercial and residential projects of the latter across Mumbai metropolitan region.

GR Infraprojects: The company has emerged as L-1 bidder in financial bid opening for tenders invited by NHAI for two projects respectively – four laning of existing 2-lane stretch from Govindpur to Rajura in Maharashtra and another four laning of existing 2-lane stretch from Bamni to MH/TG border in Maharashtra.

Aurobindo Pharma: The company has approved the acquisition of business and certain assets of Veritaz Healthcare which is a pharmaceutical industry selling branded generic formulations and other health care related products.

Piramal Enterprises: The company approved allotment of 1,750 secured NCDs each of face value of Rs 10 lakh at a price of Rs 10,05,497 per debenture aggregating to Rs 175.96 crores on a private placement basis.

ICICI Bank: The bank signed an agreement for investment in India Debt Resolution Company. ICICI Bank will buy 15% stake in IDRC for Rs 7.5 crore with the first investment of Rs 3 crore by March 31.

Zensar Technologies: Opens a global delivery centre in Kolkata to support global clients and leverage local talent.

Ruchi Soya: The Rs 4,300-crore follow-on public offer was subscribed 3.6 times on the final day on Monday. SEBI, however, allowed investors other than anchor buyers to withdraw their bids for the company’s share sale citing misleading advertising, a rare such action.

Veranda Learning Solutions: Three-day IPO to open today to raise up to Rs 200 crore. Company is selling shares at Rs 130-137 apiece.

Source: Moneycontrol, Livemint,, Bloomberg, Investing 

Disclosure in pursuance of Section 19 of SEBI (RA) Regulation 2014

Elite Wealth Limited does/does not do business with companies covered in its research reports. Investors should be aware that the Elite Wealth Limited may/may not have a conflict of interest that could affect the objectivity of this report. Investors should consider this report as only information in making their investment decision and must exercise their own judgment before making any investment decision.
For analyst certification and other important disclosures, see the Disclosure Appendix, or go to www.elitewealth.in. Analysts employed by Elite Wealth Limited are registered/qualified as research analysts with SEBI in India.( SEBI Registration No.: INH100002300)
Disclosure Appendix
Analyst Certification (For Reports)
Israil Khan, Elite Wealth Limited, suhail@elitewealth.in
The analyst(s) certify that all of the views expressed in this report accurately reflect my/our personal views about the subject company or companies and its or their securities. I/We also certify that no part of my compensation was, is or will be, directly or indirectly, related to the specific recommendations or views expressed in this report. Unless otherwise stated, the individuals listed on the cover page of this report are analysts in Elite Wealth Limited.
As to each individual report referenced herein, the primary research analyst(s) named within the report individually certify, with respect to each security or issuer that the analyst covered in the report, that:
(1) all of the views expressed in the report accurately reflect his or her personal views about any and all of the subject securities or issuers; and
(2) no part of any of the research analyst’s compensation was, is, or will be directly or indirectly related to the specific recommendations or views expressed in the report.
For individual analyst certifications, please refer to the disclosure section at the end of the attached individual notes.
Research Excerpts
This note may include excerpts from previously published research. For access to the full reports, including analyst certification and important disclosures, investment thesis, valuation methodology, and risks to rating and price targets, please visit www.elitewealth.in.
Company-Specific Disclosures
Important disclosures, including price charts, are available and all Elite Wealth Limited covered companies by visiting https://www.elitewealth.in, or emailing research@elitestock.com with your request. Elite Wealth Limited may screen companies based on Strategy, Technical, and Quantitative Research. For important disclosures for these companies, please e-mail research@elitestock.com.
Options related research:
If the information contained herein regards options related research, such information is available only to persons who have received the proper option risk disclosure documents. For a copy of the risk disclosure documents, please contact your Broker’s Representative or visit the OCC’s website at https://www.elitewealth.in
Other Disclosures
All research reports made available to clients are simultaneously available on our client websites. Not all research content is redistributed, e-mailed or made available to third-party aggregators. For all research reports available on a particular stock, please contact your respective broker’s sales person.
Ownership and material conflicts of interest Disclosure
Elite Wealth Limited policy prohibits its analysts, professionals reporting to analysts from owning securities of any company in the analyst’s area of coverage. Analyst compensation: Analysts are salary based permanent employees of Elite Wealth Limited. Analyst as officer or director: Elite Wealth Limited policy prohibits its analysts, persons reporting to analysts from serving as an officer, director, board member or employee of any company in the analyst’s area of coverage.
Country Specific Disclosures
India – For private circulation only, not for sale.
Legal Entities Disclosures
Mr. Ravinder Parkash Seth is the Managing Director of Elite Wealth Ltd (EWL, henceforth), having its registered office at Casa Picasso, Golf Course Extension, Near Rajesh Pilot Chowk, Radha Swami, Sector-61, Gurgaon-122001 Haryana, is a SEBI registered Research Analyst and is regulated by Securities and Exchange Board of India. Telephone:011-43035555, Facsimile: 011-22795783 and Website: www.elitewealth.in
EWL discloses all material information about itself including its business activity, disciplinary history, the terms and conditions on which it offers research report, details of associates and such other information as is necessary to take an investment decision, including the following:
1. Reports
a) EWL or his associate or his relative has no financial interest in the subject company and the nature of such financial interest;
(b) EWL or its associates or relatives, have no actual/beneficial ownership of one per cent. or more in the securities of the subject company, at the end of the month immediately preceding the date of publication of the research report or date of the public appearance;
(c) EWL or its associate or his relative, has no other material conflict of interest at the time of publication of the research report or at the time of public appearance;
2. Compensation
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) EWL or its associates have not managed or co-managed public offering of securities for the subject company in the past twelve months;
(c) EWL or its associates have not received any compensation for investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(d) EWL or its associates have not received any compensation for products or services other than investment banking or merchant banking or brokerage services from the subject company in the past twelve months;
(e) EWL or its associates have not received any compensation or other benefits from the Subject Company or third party in connection with the research report.
3 In respect of Public Appearances
(a) EWL or its associates have not received any compensation from the subject company in the past twelve months;
(b) The subject company is not now or never a client during twelve months preceding the date of distribution of the research report and the types of services provided by EWL

 

FILING COMPLAINTS ON SCORES - EASY & QUICK

a. Register on SCORES portal

b. Mandatory details for filing complaints on SCORES:
i. Name, PAN, Address, Mobile Number, E-mail ID

c. Benefits:
i. Effective communication
ii. Speedy redressal of the grievances

SEBI : https://www.scores.gov.in/scores/complaintRegister.html